136 related articles for article (PubMed ID: 15271662)
1. Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning.
Kristo G; Yoshimura Y; Keith BJ; Stevens RM; Jahania SA; Mentzer RM; Lasley RD
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2746-53. PubMed ID: 15271662
[TBL] [Abstract][Full Text] [Related]
2. The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning.
Yoshimura Y; Kristo G; Keith BJ; Jahania SA; Mentzer RM; Lasley RD
Cardiovasc Drugs Ther; 2004 Nov; 18(6):433-40. PubMed ID: 15770430
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium.
McVey MJ; Smits GJ; Cox BF; Kitzen JM; Clark KL; Perrone MH
J Cardiovasc Pharmacol; 1999 May; 33(5):703-10. PubMed ID: 10226856
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
5. In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling.
Reid EA; Kristo G; Yoshimura Y; Ballard-Croft C; Keith BJ; Mentzer RM; Lasley RD
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2253-9. PubMed ID: 15653762
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.
Glover DK; Ruiz M; Takehana K; Petruzella FD; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3164-71. PubMed ID: 17308004
[TBL] [Abstract][Full Text] [Related]
7. Amp 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors.
Xu Z; Downey JM; Cohen MV
J Cardiovasc Pharmacol; 2001 Sep; 38(3):474-81. PubMed ID: 11486252
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.
Button L; Mireylees SE; Germack R; Dickenson JM
Exp Physiol; 2005 Sep; 90(5):747-54. PubMed ID: 15964902
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of AMP 579, a novel cardioprotective adenosine A1/A2A receptor agonist, on native IKr and cloned HERG current.
Saegusa N; Sato T; Ogura T; Komuro I; Nakaya H
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):492-9. PubMed ID: 15558241
[TBL] [Abstract][Full Text] [Related]
10. Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2.
Kis A; Baxter GF; Yellon DM
Cardiovasc Drugs Ther; 2003; 17(5-6):415-25. PubMed ID: 15107596
[TBL] [Abstract][Full Text] [Related]
11. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Sheldrick A; Gray KM; Drew GM; Louttit JB
Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
[TBL] [Abstract][Full Text] [Related]
12. Protection of IB-MECA against myocardial stunning in conscious rabbits is not mediated by the A1 adenosine receptor.
Kodani E; Bolli R; Tang XL; Auchampach JA
Basic Res Cardiol; 2001 Sep; 96(5):487-96. PubMed ID: 11605996
[TBL] [Abstract][Full Text] [Related]
13. Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state.
Dana A; Baxter GF; Walker JM; Yellon DM
J Am Coll Cardiol; 1998 Apr; 31(5):1142-9. PubMed ID: 9562020
[TBL] [Abstract][Full Text] [Related]
14. The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium.
Kristo G; Yoshimura Y; Niu J; Keith BJ; Mentzer RM; Bünger R; Lasley RD
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H517-24. PubMed ID: 14551043
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium.
Lasley RD; Jahania MS; Mentzer RM
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1660-6. PubMed ID: 11247777
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.
Puri N; Mohey V; Singh M; Kaur T; Pathak D; Buttar HS; Singh AP
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):361-8. PubMed ID: 26728617
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A₂A and A₂B receptors are both required for adenosine A₁ receptor-mediated cardioprotection.
Zhan E; McIntosh VJ; Lasley RD
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1183-9. PubMed ID: 21743001
[TBL] [Abstract][Full Text] [Related]
18. Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
Gazoni LM; Walters DM; Unger EB; Linden J; Kron IL; Laubach VE
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):440-6. PubMed ID: 20398911
[TBL] [Abstract][Full Text] [Related]
19. Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent.
Lasley RD; Keith BJ; Kristo G; Yoshimura Y; Mentzer RM
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H785-91. PubMed ID: 15833799
[TBL] [Abstract][Full Text] [Related]
20. Functional interplay between adenosine A
Constantino LC; Pamplona FA; Matheus FC; de Carvalho CR; Ludka FK; Massari CM; Boeck CR; Prediger RD; Tasca CI
Neurobiol Learn Mem; 2021 Apr; 180():107422. PubMed ID: 33691195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
